Breast Cancer Research Stamp Act of 2001

House Bill 2725 - Breast Cancer Research Stamp Act of 2001: Overview, Status, and Impact

Hozzl · 2023-01-16T17:32:53Z

Explore the details of House Bill 2725 Breast Cancer Research Stamp Act of 2001 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Government Operations and Politics. Stay informed on legislative developments.

1/16/2023, 5:32 PM

Congressional Summary of HR 2725

Breast Cancer Research Stamp Act of 2001 - Amends Federal postal law to provide that any limitation in the Semipostal Authorization Act relating to whether more than one semipostal (a postage stamp issued by the U.S. Postal Service, at a premium, in order to help provide funding for a national public interest) may be offered for sale at the same time, shall not apply to the breast cancer research special stamps issued by the U.S. Postal Service. Extends the Service's authority to issue such stamps through July 29, 2008.

Revises the differential amount of the special rate of postage for the breast cancer research stamp to not less than 15 percent of the regular first-class rate (currently, not to exceed 25 percent of first-class). Requires the special rate to be evenly divisible by five.

Read the Full Bill

Formatted Text PDF

Current Status of Bill HR 2725

Bill HR 2725 is currently in the status of Bill Introduced since August 2, 2001. Bill HR 2725 was introduced during Congress 107 and was introduced to the House on August 2, 2001. Bill HR 2725's most recent activity was Executive Comment Requested from DOD. as of June 18, 2002